ADVFN US – Market Content Editor
-
Dow Jones, S&P, Nasdaq, Wall Street Futures, Netflix Earnings in Focus as Wall Street Awaits Busy Reporting Day; Zions Bancorp Rises Post-Market
U.S. stock futures slipped slightly on Tuesday as investors prepared for a wave of major corporate earnings reports that could provide new clues about the health of both Corporate America and the broader economy. Netflix (NASDAQ:NFLX) will headline the results after the closing bell, while Zions Bancorporation (NASDAQ:ZION) climbed in late trading following reassurance from…
-
Gold Retreats from Record Highs as Trade Optimism and Profit-Taking Weigh on Prices
Gold prices slipped in Asian trading on Tuesday, easing from unprecedented highs as traders locked in profits and signs of improving U.S.–China trade relations tempered demand for safe-haven assets. Spot gold fell 0.8% to $4,322.95 per ounce by 02:27 ET (06:27 GMT), pulling back from Monday’s record peak of $4,381.21/oz after a sustained rally. U.S.…
-
Oil Falls Again as Market Grapples With Oversupply and Trade Uncertainty
Oil prices declined for a second consecutive session on Tuesday, weighed down by growing fears of oversupply and ongoing trade tensions between the U.S. and China, the world’s two largest consumers of crude. Brent Crude futures slipped 30 cents, or 0.49%, to $60.71 a barrel as of 07:46 GMT. West Texas Intermediate (WTI) for November…
-
U.S. Dollar Firms as Trade Hopes Calm Markets; Pound Slips on Borrowing Data
The U.S. dollar edged higher on Tuesday, regaining some ground after last week’s sharp decline triggered by banking sector worries. Optimism around potential progress in upcoming trade talks between the U.S. and China offered additional support to the greenback. At 04:25 ET (08:25 GMT), the U.S. Dollar Index — which tracks the dollar against six…
-
U.S. Stocks Move Sharply Higher Amid Rally By Apple
Following the upward move seen over the course of last Friday’s session, stocks showed a more significant move to the upside during trading on Monday. The major averages all moved sharply higher, climbing back within striking distance of their record highs. The major averages moved roughly sideways after an early rally, hovering firmly in positive…
-
Dow Jones, S&P, Nasdaq, Futures Point Higher as Tariff Exemptions Fuel Optimism on Wall Street
U.S. stock index futures indicated a positive open on Monday, hinting at a continuation of last week’s upward momentum after investors received a potentially market-friendly trade development from Washington. According to a The Wall Street Journal report, the Trump administration has been softening its tariff policy, quietly granting exemptions to some products that had previously…
-
IonQ Shares Gain After Joining Italy’s Q-Alliance Quantum Hub Initiative
IonQ (NYSE:IONQ) climbed 3.5% in premarket trading after announcing it has become a founding member of Q-Alliance, a new initiative aimed at establishing a quantum technology hub in Lombardy, Italy. The partnership supports Italy’s National Strategy for Quantum Technologies, bringing together public and private players to build a robust quantum ecosystem. The launch took place…
-
Cooper Shares Climb as Activist Jana Partners Takes Stake and Pushes for Strategic Shake-Up
Cooper Companies (NASDAQ:COO) saw its shares rise over 4% in premarket trading Monday after the Wall Street Journal reported that activist investor Jana Partners has built a stake in the company and intends to push for major strategic changes — including the potential combination of Cooper’s contact lens business with Bausch + Lomb. Jana reportedly…
-
Beyond Meat Shares Skyrocket 70% as Short Squeeze Speculation Mounts
Beyond Meat (NASDAQ:BYND) shares surged 70% in premarket trading Monday, jumping from $0.64 to $1.08, extending the strong upward momentum seen on Friday, when the stock gained 24%. The rally appears to be driven by growing speculative interest in small-cap stocks with high short interest, making Beyond Meat particularly susceptible to a short squeeze. Recent…
-
Olema Shares Sink 28% as Roche Trial Results Weigh on Breast Cancer Drug Outlook
Olema Pharmaceuticals (NASDAQ:OLMA) plunged 28% in premarket trading Monday after releasing data from an early- to mid-stage breast cancer study that was overshadowed by disappointing results from Roche. Matthew Biegler, analyst at Oppenheimer, noted that Olema’s “stellar” combination therapy data risk being eclipsed by Roche’s breast cancer trial outcome, “which missed the buy-side’s mark.” Roche’s…